Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Impella® Support in Patients With ST-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock: The RECOVER IV Trial

NCT05506449 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT05506449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05506449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Impella® Support in Patients With ST-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock: The RECOVER IV Trial
Lead sponsor
Abiomed Inc.
Phase
Not applicable
Overall status
Terminated
Start date
October 28, 2023
Completion date
December 6, 2024
Enrollment
4 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, st-segment elevation myocardial infarction (stemi)